Antonio Abbadessa Selected Research

2- (2- methoxybenzyl)- 3- (1,10- phenanthrolin- 2- yl)isoxazolidin- 5- yl)methanol

1/2018

DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Abbadessa Research Topics

Disease

1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2020
1	Visceral Leishmaniasis (Kala Azar) 11/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2009
1	Pathologic Complete Response 03/2009
1	Pure Red-Cell Aplasia 03/2009
1	Lymphoma (Lymphomas) 07/2004

Drug/Important Bio-Agent (IBA)

1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	AzidesIBA 11/2018
1	Pentamidine (NebuPent)FDA LinkGeneric 11/2018
1	PolymersIBA 11/2018
1	Hyaluronic Acid (Hyaluronan)IBA 11/2018
1	Alkynes (Acetylenes)IBA 11/2018
1	Antiparasitic Agents (Antiparasitics)IBA 11/2018
1	2- (2- methoxybenzyl)- 3- (1,10- phenanthrolin- 2- yl)isoxazolidin- 5- yl)methanolIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Intercalating AgentsIBA 01/2018
1	Rituximab (Mabthera)FDA Link 03/2009
1	Monoclonal AntibodiesIBA 03/2009
1	Methotrexate (Mexate)FDA LinkGeneric 07/2004
1	Temozolomide (Temodar)FDA LinkGeneric 07/2004

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2009
1	Immunotherapy 12/2020
1	Drug Therapy (Chemotherapy) 07/2004